NILSON TAVARES POPPI

(Fonte: Lattes)
Índice h a partir de 2011
4
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/13 - Laboratório de Genética e Cardiologia Molecular, Hospital das Clínicas, Faculdade de Medicina

Resultados de Busca

Agora exibindo 1 - 8 de 8
  • conferenceObject
    Obstructive Sleep Apnea Is Extremely Common And Associated With Myocardial Ischemia In Patients With Refractory Angina
    (2014) GEOVANINI, G. R.; PEREIRA, A. C.; GOWDAK, L. H. W.; DOURADO, L. O.; POPPI, N.; CESAR, L. M.; DRAGER, L. F.; LORENZI-FILHO, G.
  • conferenceObject
    Obstructive Sleep Apnea In The Spectrum Of Coronary Artery Disease: Stable Versus Refractory Angina Patients
    (2013) GEOVANINI, G. R.; DANZI-SOARES, N.; DOURADO, L. O. C.; POPPI, N. T.; PEREIRA, A. C.; GOWDAK, L. W.; DRAGER, L. F.; LORENZI-FILHO, G.
  • conferenceObject
    Clinical impact of medical intensive treatment on functional class in patients initially diagnosed as refractory angina
    (2012) DOURADO, Luciana O. C.; POPPI, Nilson T.; PEREIRA, Alexandre C.; CESAR, Luiz Antonio M.; GOWDAK, Luis Henrique W.
    Introduction: Refractory angina is a major clinical challenge. Patients (pt) usually have significant functional impairment due to disabling symptoms, which greatly adversely impact their quality of life. Many pt may be erroneously diagnosed as refractory angina, if not on intensive medical therapy. Objectives: To evaluate the impact of intensive medical treatment on angina functional class in pt initially diagnosed as refractory angina. Methods: 45 pt (31 men, 59±13 years) were included based on the following criteria: 1) disabling symptoms; 2) objectively documented myocardial ischemia; 3) coronary anatomy unsuitable for myocardial revascularization procedures. Medical visits were scheduled every 4 weeks during a 3-month period (Vo to V3). Angina functional class was recorded in each visit as proposed by the Canadian Cardiovascular Society (CCS). Medical therapy was strongly encouraged to be optimized based on patient’s tolerance. Statistical analysis included the Student s t-test (continuous variables), the chi-square test (categorical variables), and the Wilcoxon test (changes in functional class). Results: There was an overall improvement in CCS class between V0 to V3 (p,<0,001), with 30 pt (66.7%) improving at least 1 class. In 14 pt (31.1%) there was no difference and in only 1 pt (2.2%) there was worsening of CCS class. In V0 and V3, anti-ischemic drugs were used as follows (%), respectively: beta-blockers (96 vs. 96), calcium channel blockers (78 vs. 84), long-acting nitrates (96 vs. 100), and trimetazidine (38 vs. 93). Mean daily dosages (mg)of selected drugs were: atenolol 105±49 to 113±59 (P=0.16); carvedilol 44±16 to 55±20 (P=0.06); amlodipine 7±3 to 8±3(P=0.12); isossorbide 95±28 to 106±24(P=0.09). There was a non-significant 4.4% decrease in the mean heart rate (bpm) from 66±11 to 63±9(P=0.10), and a non-significant 4% reduction in mean systolic (SBP) and diastolic (DBP) blood pressure: SBP - 128±23 to 123±23mmHg (P=0.10), and DBP -75±11 to 72±14mmHg (P=0.11). Conclusion: Pt enrolled in this clinical program, although initially diagnosed as refractory angina, experienced a significant improvement in their functional class. This could not be attributed to an increase in anti-ischemic drugs or to an hemodynamic effect. We believe that the regular visits at shorter intervals may have led to a better treatment adherence, emotional easiness and self-confidence. This study exemplifies how complex is the relationship between extensiveness of the disease and functional impairment.
  • conferenceObject
    Uncovering the meaning of the Canadian Cardiovascular Society classification in patients with stable angina
    (2012) DOURADO, Luciana O. C.; POPPI, Nilson T.; BITTENCOURT, Marcio S.; PEREIRA, Alexandre C.; CESAR, Luiz Antonio M.; GOWDAK, Luis Henrique
    Introduction: Angina is the hallmark of coronary artery disease (CAD). More than 30 years ago, the Canadian Cardiovascular Society (CCS) proposed a classification regarding the functional impairment imposed by angina pectoris. There is, however, a major caveat with that classification that might lead to an underestimation of the extension of CAD: either patients (pt) become self-limited as a strategy to avoid exertional pain or they very often depend on the use of nitrates to tolerate different levels of exercise. Objectives: To determine the relationship between CCS classification and the frequency of angina attacks and the consumption of sublingual, short-acting nitrates tablets. Methods: 72 pt (60 men,59±13 years) with stable angina due to CAD were included. All pt had to fulfill an angina diary during a 4-week period, in which they recorded the number of daily episodes of angina and the number of short-acting nitrates taken. Investigators also recorded the functional class according to the CCS classification (I to IV). Continuous data were expressed as mean SD and ordinal variables, as percentage. Spearman’s rank correlation coefficient was applied to determine correlation between variables. Results: The distribution (n, %) of pt according to the CCS was CCS I (9, 12.5%), CCS II (41, 57%), CCS III (7, 9.5%), and CCS IV (15, 21%). The mean number of angina attacks per week and the mean number of sublingual nitrates tablets taken per week were, respectively,3.0±3.0 and 1.2±1.4 (CCS I), 2.7±3.6 and 1.5±1.9 (CCS II), 7.8±4.6 and 1.6±2.3 (CCSIII), and 5.5±3.7 and 2.1±3.3 (CCS IV). We found a strong, positive association between angina episodes and sublingual nitrates tablets per week (r=0.511; P<0.0001), a positive association between CCS and angina episodes per week (r=0.34; P=0.003), but no association between CCS and sublingual nitrates tablets per week (r=0.103; P=0.38).Conclusion: The CCS functional classification is a valid tool to predict the intensity of exercise level that evokes angina. However, it fails in estimating the frequency of the angina attacks. So, the true impairment in quality of life in patients with CAD (which depends not only on exercise tolerance [intensity] but also on angina frequency) may be underestimated by the CCS classification. More likely, pt may avoid certain activities previously known to them to provoke angina or use short-acting nitrates before angina actually occurs. This information must be carefully obtained by a detailed medical history.
  • conferenceObject
    Coronary flow reserve but not ischemia is a strong predictor of mortality in 551 outpatients referred for stress myocardial perfusion by Rubidium-82 PET imaging
    (2019) POPPI, N. Tavares; SOARES JUNIOR, J.; MENEGHETTI, J. C.; MIOTO, B. Mahler; GIORGI, M. C. P.; IZAKI, M.; CESAR, L. A. Machado
  • conferenceObject
    The Effectiveness of Intensive Medical Treatment of Patients Initially Referred as Refractory Angina: Preliminary Results
    (2012) DOURADO, Luciana O.; POPPI, Nilson T.; PEREIRA, Alexandre C.; CESAR, Luiz Antonio M.; KRIEGER, Jose Eduardo; GOWDAK, Luis Henrique W.
  • conferenceObject
    Obstructive sleep apnoea is highly frequent in consecutive patients with refractory angina
    (2012) GEOVANINI, G.; DRAGER, L.; DOURADO, L. O. C.; POPPI, N. T.; PEREIRA, A. C.; GOWDAK, L. H. W.; LORENZI-FILHO, G.
    Purpose: Obstructive sleep apnoea (OSA) is common among patients with stable coronary artery disease and may contribute to poor cardiovascular outcome. OSA has not been investigated in patients with refractory angina, a debilitating condition characterized by persistent symptoms despite optimized medical therapy. Methods: Consecutive patients with multi-vessel coronary disease by angiography and refractory angina (severe ischemic symptoms that persist despite optimal medical therapy and whom coronary revascularization procedures are no longer feasible or helpful) were recruited from a specialized out patient clinic. Regardless of sleep complaints, all patients were evaluated by standard overnight polysomnography, symptoms of excessive daytime sleepiness by Epworth Sleepiness Scale (ESS) and one week diary of angina. Results: We evaluated 31 patients (18 males, age: 62±10y, body mass index: 29.8±4.5kg/m2). Co-morbidities were common (dyslipidemia 100%, hypertension 93% and diabetes 61%) and all patients presented persistent angina despite optimal anti-ischemic medical therapy and preserved systolic function (ejection fraction on echocardiography: 53±11%). Patients presented poor sleep quality, poor sleep efficiency (60±16%) and the prevalence of OSA (AHI>15) and severe OSA (AHI>30) was 71 and 55%, respectively. As compared with patients without OSA patients with OSA presented similar age, gender, BMI (28.2±5 vs. 30.4±4.5kg/m2, p=0.26) similar ESS (10±6 vs. 11±6), non-significant trend to higher frequency of diurnal (66 vs. 91%, p=0.13) and nocturnal angina (45 vs. 77%, p=0.10). Conclusions: This preliminary study showed a high frequency of OSA in consecutive patients with refractory angina. Traditional risk factors for OSA, including age, male gender and BMI did not discriminate patients with OSA. Non-significant trends to higher frequency of diurnal and nocturnal angina suggest that OSA may contribute to trigger angina symptoms.
  • conferenceObject
    Predictors of death and myocardial infarction in patients with refractory angina
    (2014) POPPI, N. Tavares; DOURADO, L. O. C.; VENTURINI, G.; ADAM, E. L.; LEITE, T. N. P.; CESAR, L. A. Machado; PEREIRA, A. C.; GOWDAK, L. H. W.